Rayzebio Inc (RYZB) Return on Investment ROI from the third quarter of 2023 to third quarter of and for the year 2023, average high and low, overall ranking from Sep 30 2023 to - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Rayzebio Inc   (NASDAQ: RYZB)


Rayzebio Inc's ROI from its third quarter of 2023 to the third quarter of and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Rayzebio Inc's ROI in the third quarter of 2023?
Rayzebio Inc achieved a return on average invested assets (ROI) of 117.64 % in its third quarter of 2023, this is above RYZB's average return on investment of -12.41%.
Rayzebio Inc invested over the 12 months ending in its third quarter of 2023 $320 million

ROI decreased relative to the period ending Sep 30 2022, due to the decline in net income.

Within the Healthcare sector 293 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2022 from to 3297.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Sep 30 2022)
III. Quarter


Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 578 703 0 0 0
Return On Investment (TTM) 117.64 % 224.76 % - - -
RYZB's Overall Ranking # 3297 # # # #
Seq. Investment Change TTM 82.25 % - - - -
Seq. Net Income Change TTM -4.61 % - - - -
Net Income (TTM) in Millions 377 395 0 0 0

RYZB Company Profile >> Back to RYZB Roi Comparisons >> See Annual RYZB Return On Investment



Return On Investment RYZB's Ranking
Within: No.
Industry # 103
Sector # 294
Overall # 3297

Return On Investment Statistics
High Average Low
-12.41 %
-12.41 %
-12.41 %
(Sep 30 2023)  







Financial Statements
Rayzebio Inc's III. Quarter Investments $ 578 Millions RYZB's Balance sheet
Rayzebio Inc's III. Quarter Income $ -18 Millions Quarterly RYZB's Income Statement
RYZB's Income by Division See RYZB's Income by Division


RYZB Annual Return On Investment




Total Investments in Millions 0 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 0 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RYZB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RYZB's Competitors
Subscribers only: Roi for Rayzebio Inc's Suppliers
Subscribers only: Return On Investment for RYZB's Customers

Other Ratios
RYZB's Roa RYZB's Inventory Turnover Ratio RYZB's Growth Rates RYZB's Dividend Statistics
RYZB's Profitability Ratios RYZB's Asset Turnover Ratio RYZB's Dividend Growth
RYZB's Roe RYZB's Valuation Ratios RYZB's Financial Strength Ratios RYZB's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI
Ir med Inc   300.96 %
Tff Pharmaceuticals Inc  241.72 %
Therapeuticsmd Inc   179.97 %
Inhibitor Therapeutics Inc   100.93 %
Glucotrack Inc   88.82 %
Scynexis Inc   79.06 %
Biomx Inc  76.77 %
Ladrx Corporation  74.45 %
Molecular Templates Inc   73.94 %
Avalo Therapeutics Inc   67.67 %
Opus Genetics Inc   65.54 %
Dariohealth Corp   57.65 %
Cv Sciences Inc   51.59 %
Elite Pharmaceuticals Inc   47.02 %
Gyre Therapeutics Inc   45.47 %
Star Equity Holdings Inc   44.42 %
Idexx Laboratories Inc  43.85 %
Entera Bio Ltd   41.70 %
Zymeworks Inc   39.50 %
Medpace Holdings Inc   38.76 %
Lite Strategy Inc   38.41 %
Enzo Biochem Inc  38.07 %
Northview Acquisition Corp  37.67 %
Mettler toledo International Inc   33.97 %
Semler Scientific inc   30.96 %
Escalon Medical Corp   30.94 %
Nrc Health  30.72 %
Vaso Corporation  29.37 %
Denali Therapeutics Inc   29.23 %
Shockwave Medical Inc   28.94 %

Date modified: 2026-09-26T07:42:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.